发明名称 |
Antigenic peptides derived from telomerase |
摘要 |
This invention relates to proteins or peptides that elicit T cell mediated immunity, and to cancer vaccines and compositions for anti-cancer treatment comprising such proteins or peptide fragments. This invention also relates to pharmaceutical compositions comprising the proteins or peptides and methods for generating T lymphocytes capable of recognizing and destroying tumor cells in a mammal. More specifically, a telomerase protein or peptide for use in a method of treatment or prophylaxis of cancer is provided. In a preferred embodiment, the method comprises generating a T cell response against telomerase.
|
申请公布号 |
US2006106196(A1) |
申请公布日期 |
2006.05.18 |
申请号 |
US20060332378 |
申请日期 |
2006.01.17 |
申请人 |
GEMVAX AS |
发明人 |
GAUDERNACK GUSTAV;ERIKSEN JON A.;MOLLER MONA;GJERTSEN MARIANNE K.;SAETERDAL INGVIL;SAEBOE-LARSEN STEIN |
分类号 |
A61K38/10;C12N15/09;A61K31/711;A61K38/00;A61K38/45;A61K38/53;A61K39/00;A61K39/39;A61P35/00;A61P37/04;C12N5/07;C12N9/12 |
主分类号 |
A61K38/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|